Glow Lifetech Corp. (GLWLF)
USD 0.04
(-10.06%)
USD 0.04
(-10.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.44 Million USD | -15.21% |
| 2022 | 1.7 Million USD | -42.79% |
| 2021 | 2.97 Million USD | 145756.09% |
| 2020 | 2040.03 USD | -87.13% |
| 2019 | 15.85 Thousand USD | 62.56% |
| 2018 | 9752.53 USD | -78.15% |
| 2017 | 44.63 Thousand USD | 436.13% |
| 2016 | 8324.82 USD | 6.79% |
| 2015 | 7795.70 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.52 Million USD | 8.05% |
| 2024 Q2 | 1.71 Million USD | 13.59% |
| 2023 Q1 | 1.56 Million USD | -8.07% |
| 2023 Q4 | 1.44 Million USD | -1.77% |
| 2023 Q3 | 1.46 Million USD | -8.49% |
| 2023 Q2 | 1.6 Million USD | 2.6% |
| 2023 FY | 1.44 Million USD | -15.21% |
| 2022 Q2 | 2.26 Million CAD | -12.61% |
| 2022 Q1 | 2.58 Million CAD | -13.08% |
| 2022 Q4 | 1.7 Million USD | -21.65% |
| 2022 FY | 1.7 Million USD | -42.79% |
| 2022 Q3 | 2.17 Million USD | -3.88% |
| 2021 Q1 | 4.44 Million CAD | 170780.07% |
| 2021 FY | 2.97 Million USD | 145756.09% |
| 2021 Q4 | 2.97 Million CAD | -14.86% |
| 2021 Q3 | 3.49 Million CAD | -12.34% |
| 2021 Q2 | 3.98 Million CAD | -10.23% |
| 2020 FY | 2040.03 USD | -87.13% |
| 2020 Q4 | 2599.00 CAD | 42.96% |
| 2020 Q3 | 1818.00 CAD | -35.78% |
| 2020 Q2 | 2831.00 CAD | -24.63% |
| 2020 Q1 | 3756.00 CAD | -81.73% |
| 2019 FY | 15.85 Thousand USD | 62.56% |
| 2019 Q4 | 20.55 Thousand CAD | 0.0% |
| 2018 FY | 9752.53 USD | -78.15% |
| 2017 FY | 44.63 Thousand USD | 436.13% |
| 2016 FY | 8324.82 USD | 6.79% |
| 2015 FY | 7795.70 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 96.284% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 80.008% |
| SQZ Biotechnologies Company | 107.18 Million USD | 98.653% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 86.324% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 98.892% |
| Mesoblast Limited | 667.9 Million USD | 99.784% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1894.569% |
| Genus plc | 1.02 Billion USD | 99.86% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -6.259% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -189.23% |
| Marizyme, Inc. | 22.01 Million USD | 93.444% |
| ContraFect Corporation | 20.67 Million USD | 93.02% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -130.203% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -269.748% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -277.671% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -0.792% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 65.187% |
| MultiCell Technologies, Inc. | 126.22 USD | -1143435.097% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -53.601% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 98.877% |
| EV Biologics, Inc. | 431.71 Thousand USD | -234.335% |
| Q BioMed Inc. | 3.51 Million USD | 58.943% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 95.897% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -87.294% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -452.429% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1855.283% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 99.688% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 95.191% |
| Skye Bioscience, Inc. | 11.94 Million USD | 87.912% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 56.433% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 47.444% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 26.291% |
| IMV Inc. | 31.33 Million USD | 95.394% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -109.949% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 44.554% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1295.342% |
| Alpha Cognition Inc. | 2.45 Million USD | 41.139% |
| HST Global, Inc. | 1526.00 USD | -94485.19% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Halberd Corporation | 10.13 Thousand USD | -14147.063% |
| Enzolytics Inc. | 361.7 Million USD | 99.601% |
| Resverlogix Corp. | 8.11 Million USD | 82.214% |
| Affymax, Inc. | 7.44 Million USD | 80.608% |
| SYBLEU INC | 330.46 Thousand USD | -336.765% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 23.138% |
| argenx SE | 4.54 Billion USD | 99.968% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 94.835% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 96.974% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -6235.85% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 83.871% |
| AVAX Technologies, Inc. | 7.37 Million USD | 80.435% |
| Zenith Capital Corp. | 7410.00 USD | -19378.677% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.957% |
| Ember Therapeutics, Inc. | 184.00 USD | -784340.217% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -348.522% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -452.245% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.677% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 0.378% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | 52.287% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 97.261% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -55.542% |
| BioStem Technologies, Inc. | 14.56 Million USD | 90.087% |
| ONE Bio Corp. | 70.08 Million USD | 97.941% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2428.059% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -62383.55% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -46.095% |
| Agentix Corp. | 261.39 Thousand USD | -452.186% |
| LadRx Corporation | 2.3 Million USD | 37.459% |
| Cell Source, Inc. | 195.17 Thousand USD | -639.541% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -200.354% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -308.173% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -308.173% |
| NovAccess Global Inc. | 62.24 Thousand USD | -2218.741% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -125.648% |
| Itoco Inc. | 1.4 Million USD | -3.093% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1408.902% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1261.67% |
| Kadimastem Ltd | 2.3 Million USD | 37.356% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1790.366% |
| CytoDyn Inc. | 11.13 Million USD | 87.039% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -909.547% |
| Mobile Lads Corp. | 52.00 USD | -2775611.538% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -7972.539% |
| Qrons Inc. | 420.00 USD | -343559.524% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -274.443% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -161.423% |
| Rebus Holdings, Inc. | 5000.00 USD | -28767.4% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -252.538% |
| International Stem Cell Corporation | 5.39 Million USD | 73.221% |
| Bioxytran, Inc. | 137.63 Thousand USD | -948.671% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 90.379% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 91.294% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1727.051% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -66.926% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 80.799% |
| Neutra Corp. | 2851.00 USD | -50526.798% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 95.546% |
| PureTech Health plc | 693.97 Million USD | 99.792% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 82.117% |
| IXICO plc | 15.84 Million USD | 90.89% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 82.572% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 98.603% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Cellectis S.A. | 333.99 Million USD | 99.568% |